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Abstract 
cis-Parinaric acid (PnAc), a fluorescent, polyunsaturated fatty acid, was used to measure lipid peroxidation during 
simulated ischemia nd reperfusion in cultured neonatal rat cardiomyocytes. PnAc was used both as free fatty acid, inserted 
in the membranes following cultivation of the cells, as well as constituent of the cellular complex lipids by metabolically 
integrating the fatty acid during growth. In the insertion experiments a pre-incubation with DL-aminocarnitine, an inhibitor 
of [~-oxidation, was necessary to prevent loss of fluorescent signal. Such a pre-incubation resulted in an enrichment of PnAc 
in the sarcolemma: In pre-treated cells 57 _+ 1.3% of total inserted PnAc is present in the sarcolemma compared to 
27 _+ 5.7% in cells containing the integrated probe. Both methods to introduce PnAc into the cells were compared with 
respect o their sensitivity for an externally applied oxidative stress and thereafter lipid peroxidation during simulated 
ischemia nd reperfusion was assayed. Going from normoxic to ischemic onditions lipid peroxidation did not increase and 
remained at a low level. When the ischemic ells were subsequently subjected to reperfusion (reintroduction of both oxygen 
and glucose), large scale lipid peroxidation was obvious. When, on the other hand, oxygen alone was reintroduced 
(reoxygenation) o increased lipid peroxidation was observed. These observations led to the conclusion that ischemia does 
not lead to an enhanced lipid peroxidation and that resumption of metabolic activity during reperfusion is necessary to 
induce lipid peroxidation. © 1997 Elsevier Science B.V. 
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1. Introduction 
A growing number of studies provide support for 
the hypothesis that free radicals contribute to is- 
chemic and reperfusion injury in the myocardium 
[1-4]. In particular eactive oxygen species such as 
the superoxide anion (Oj-), which was shown to be 
* Corresponding author. Fax: + 31-30-2522478; E-mail: 
h.g.steenbergen@chem.ruu.nl 
generated in the heart during reperfusion following 
an ischemic period [5-7], may be responsible for 
extensive damage brought about in DNA, protein and 
lipids. 
Several mechanisms are proposed to explain the 
formation of oxygen radicals (for review see [4]). 
During ischemia, the catabolism of cellular ATP 
results in increased levels of hypoxanthine and xan- 
thine, while xanthine dehydrogenase i  converted into 
xanthine oxidase. Xanthine oxidase mediated 
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(hypo)xanthine degradation is accompanied by 0 i -  
and H202 formation, especially when 0 2 becomes 
available during reperfusion. Combined with the re- 
lease of iron from ferritin, "OH radicals are formed. 
Another source of oxygen radicals may be related to 
a fully reduced and possibly damaged mitochondrial 
respiratory chain. Whereas under normal conditions, 
only a small amount of the oxygen which is reduced 
in the mitochondrial respiratory chain is converted 
into superoxide anion (O 2 ), the reintroduction of O 2 
and re-establishment of mitochondrial ctivity in the 
ischemic cell may lead to an enhanced formation of 
O 2- [8]. The superoxide radical is quickly reduced to 
hydrogen peroxide which will be eliminated by cata- 
lase and glutathione peroxidase action but can be 
converted also, in the presence of iron, to the very 
reactive hydroxyl radical "OH [9] and may cause 
damage of several cell components. 
Enhanced peroxidative damage may result further- 
more from an inhibition of the regular intracellular 
enzymatic radical scavenging system, mainly consist- 
ing of the enzymes superoxide dismutase, catalase 
and glutathione peroxidase. Such an inhibition, in 
vivo, was reported by Simmons and Jamall [10] and 
Coudray et al. [11], although in studies performed 
with isolated hearts such an inhibition was not ob- 
served [12]. 
Lipid peroxidation during ischemia nd subsequent 
reperfusion has been assayed with a wide variety of 
methods uch as the determination f thiobarbituretic 
acid reactive components (TBARS) and other break- 
down products of lipid peroxides or the measurement 
of diene conjugation following lipid extraction and 
purification by HPLC or GLC. In the present study 
the approach to quantify lipid peroxidation with cis- 
parinaric acid (PnAc) has been applied [13,14]. cis- 
Parinaric acid is a polyunsaturated natural fatty acid 
with a chain length of 18 C atoms, containing four 
double bonds in a conjugated form. This double bond 
system unites several properties convenient to study 
of lipid peroxidation: It makes the probe very suscep- 
tible to lipid peroxidation and it gives the probe its 
fluorescent properties. The loss of fluorescence upon 
damage of the double bond system is a direct indica- 
tor for the peroxidative stress and damage. This 
allows us to follow directly the first step in lipid 
peroxidation: The abstraction of a H atom and double 
bond rearrangement. 
Aim of this study was to measure the occurrence 
of lipid peroxidation during ischemia nd subsequent 
reintroduction of oxygen and glucose in a direct way. 
Therefore, the original method to measure lipid per- 
oxidation with PnAc, which was based on the addi- 
tion and insertion of the free fatty acid into vesicles 
and the erythrocyte membranes, was adapted for use 
in cultured neonatal cardiomyocytes. Next to this, we 
were able to metabolically integrate PnAc in the 
lipids of spontaneous beating neonatal rat heart cells 
(cardiomyocytes). These two methods of introducing 
PnAc into the cardiomyocytes were compared, and 
tested for their sensitivity towards chemically in- 
duced oxidative stress, and the distribution of the 
probe in the cells was determined. Subsequently both 
methods were applied to the ischemia-reperfusion 
model system to investigate the initial stages of lipid 
peroxidation. 
The results indicate that lipid peroxidation does 
not occur during the ischemic period itself. Equally 
reoxygenation, i.e., the re-introduction of oxygen 
alone after an ischemic insult, does not result in an 
increased level of lipid peroxidation. During reintro- 
duction of both oxygen and substrate however large 
scale lipid peroxidation is obvious. 
2. Materials and methods 
2.1. Cell culture 
Culturing of the cells was done according to a 
modification of the method of Harary and Farley [15]. 
Neonatal rats (1-2 days old) were decapitated, their 
hearts were excised and minced. The mince was 
incubated in a spinner flask at 37°C with 0.1-0.05% 
trypsin (Difco, Detroit, MI; in 137 mM NaC1, 5 mM 
KC1, 4 mM NaHCO 3, 5 mM glucose and penicillin 
(100 000 units 1 l)/streptomycin (100 mg 1- ~)). The 
incubation fluid was decanted and new medium was 
added. The incubation medium from the first three 
incubations (10 min each) was discarded and during 
the next 8 incubations the mince was almost com- 
pletely digested. The incubation media were spun (8 
min, 430 g) and resuspended in growth medium 
(Gibco, Paisley, UK, HamF10 supplemented with 
10% fetal calf serum, 10% horse serum, 10 ~M 
Arabinose C to inhibit fibroblast growth and CaC1 z 
(final concentration 1 mM)). The cells were plated in 
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Falcon 3003 dishes (Falcon plastics, Sumter, SC) for 
2-3 h, during which time fibroblasts adhere and 
myocytes remain freely suspended [16]. Finally, the 
myocytes were plated on Primaria-treated culture 
dishes (Falcon 3801, 35 mm in diameter) or on gas 
dissection discs punched from Falcon 3802 dishes 
(60 mm in diameter). Within 3 days a confluent 
monolayer of spontaneously beating cells was formed. 
Before use the dishes with cells attached were exten- 
sively washed in buffer W + containing 133 mM 
NaC1, 5 mM KC1, 1 mM MgC12, 1 mM CaCI 2, 10 
mM Tris-HC1 and 5 mM glucose, PH37o c 7.4. 
2.2. Incubation procedures 
To allow insertion of PnAc cells were washed with 
buffer W + and incubated with DL-aminocarnitine (gift 
of Hiilsmann) in buffer W + (final concentration 200 
p~M, 2 h, 37°C), to inhibit [~-oxidation [17]. Subse- 
quently PnAc was added from a concentrated stock 
solution in ethanol to a final concentration of 4 p~M. 
The incubation took place in the dark for 30 min at 
37°C. Incubation with PnAc without aminocarnitine 
pre-incubation was performed in buffer W + in the 
dark for 40 min at 0°C. 
Metabolic integration of PnAc in lipids was 
achieved by adding PnAc, on the day of isolation 
(day 0) and just before plating, to the growth medium 
in a final concentration of 30 ~M. Cells were used 
on day 3, when a confluent monolayer of sponta- 
neously beating myocytes was formed. 
2.3. Cumene hydroperoxide (CumOOH) and hydro- 
gen peroxide (H 2 02) induced peroxidation 
Cells containing PnAc were incubated in buffer 
W + in the presence of CumOOH (5 mM or 50 ~M) 
or 250 p~M H202 and 25 ~M ferrous sulphate. After 
the chosen time span, EDTA (100 p~M) was added to 
chelate the iron ions. 
2.4. Simulation of ischemia, reoxygenation and reper- 
fusion 
Simulating ischemia at a cellular level was 
achieved by using the in vitro model of Vemuri et al. 
[18] which was modified as described previously 
[19,20]. Dishes with cultured cardiomyocytes were 
washed extensively with buffer W-  (133 mM NaC1, 
5 mM KCI, 1 mM MgC12, 1 mM CaC12, l0 mM 
Tris-HC1, pH 37oc 7.4). Subsequently 1 ml buffer W-  
per dish was added. Dishes were then placed in a 
special ischemia device that consisted of a special 
Plexiglas constructed chamber which could be tightly 
closed. Two inlet/outlet tubes allowed an atmo- 
sphere of either Argon (Ar: 99.992 vol%), or normal 
air to be installed. The temperature in the chamber 
and dishes was kept at 37°C by a continuous tream 
of heated water, which circulated through the under- 
compartment of the chamber. This model has been 
described in detail and has been shown to give rise to 
morphological and biochemical changes during the 
anoxic period comparable to in vitro and in vivo 
preparations that were subjected to ischemia [19]. 
Dissolved 0 2 in the buffer falls to zero within 25 min 
after the onset of the ischemic conditions [20]. 
The control situation (normoxia) was achieved by 
placing the cells in buffer W + at 37°C. 
After simulated ischemia, reoxygenation and 
reperfusion were achieved by adding either 1.5 ml of 
fresh buffer W-  (no glucose) or 1.5 ml buffer W + to 
each dish, and allowing them to stand at 37°C for the 
required time. 
2.5. ATP measurements 
The cellular high-energy phosphate (ATP) was 
extracted with 50% ethanol for 30 min under gentle 
shaking (1 ml dish-J). An aliquot was dried under a 
stream of nitrogen and dissolved in 100 ~1 water. 
ATP was determined using an luciferine/luciferase 
assay kit (Sigma). The relative ATP levels were 
determined by comparing the absolute biolumi- 
nescence values of the different samples with those 
of control cells. 
2.6. Measurement of lactate dehydrogenase r lease 
Cell lysis was tested by measurement of lactate 
dehydrogenase (LDH) release. After control and 
'ischemic' incubations the supernatants of the cells 
were collected and the LDH activity was assayed as 
described by Van der Schaft et al. [21]. All measure- 
ments were performed in duplo, and the relative LDH 
release was determined by comparing the activities of 
the different supernatants with the activity of total 
cell homogenates. 
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2.7. Lipid extraction 2.11. Separation of free fatty acids and phospholipids 
Extraction of the phospholipids was accomplished 
by placing 2 ml of isopropanol on the 3.5 cm dishes 
with cells (or 4 ml on a 6 cm dish) [22]. Isopropanol 
was saturated with nitrogen before use and extrac- 
tions were performed at room temperature under 
nitrogen atmosphere in the dark. A standard extrac- 
tion of 60 min ensured complete xtraction. A small 
amount of plastic was extracted uring this proce- 
dure, but proved not to interfere with the fluorescence 
measurements. 
2.8. Lipid analysis 
Total phospholipid content was determined accord- 
ing to Rouser et al. [23]. After drying the samples 
under nitrogen, phospholipids were destructed in 70% 
perchloric acid (> 30 min, 180°C) and inorganic 
phosphorous content was measured. 
2.9. Measurement offluorescence 
Free PnAc was separated from PnAc integrated in 
phospholipids by means of a silica column. Neutral 
lipids, e.g., glycerides and fatty acids are washed of 
the column first with chloroform. Phospholipids are 
eluted subsequently with chloroform/methanol 1:1 
(v/v).  Fluorescence in the eluents was checked on a 
SPF Aminco spectrofluorimeter at excitation wave- 
length 324 nm and emission wavelength 420 nm. 
The percentage of residual free PnAc in the cells 
in which most of the PnAc was metabolically inte- 
grated in the complex lipids was determined after 
fatty acid extraction according to Dole with small 
adaptations by Van den Bosch and Aarsman [25]. The 
extracts were dried under nitrogen, in the dark and 
redissolved in isopropanol. The level of fluorescence 
of free fatty acid extracted in this assay was com- 
pared to the fluorescence l vel of a total lipid extract 
obtained as described above and dissolved in the 
same solvent. 
2.12. Experimental design 
All samples were extracted as mentioned above 
and prepared in 2 ml isopropanol. Fluorescence mea- 
surements were carried out at room temperature in a 
SPF Aminco spectrofluorimeter. The excitation wave- 
length was 304 nm for free parinaric acid and 324 nm 
for integrated parinaric acid. The emission was mea- 
sured at 413 and 420 nm, respectively. 
2.10. Isolation of the sarcolemma 
The sarcolemma was isolated using the gas-dissec- 
tion technique previously described by Langer et al. 
[24] and Post et al. [22]. Briefly, the disc with 
attached cells was placed at the centre of a mobile 
platform inside the dissection chamber. The platform, 
with disc, was then elevated to make a firm contact 
with the protruding inner horizontal gas outlet. Sub- 
sequently, the inlet valve was opened rapidly ( < 1 s) 
to allow the entry of N 2 (gas) at a pressure of 
1900-2000 psi. As the N 2 s t ream bursts radially over 
the surface of the monolayer, the upper surface of the 
cells is sheared open, the cellular material is blown 
out, and the sarcolemma is left in a fenestrated layer 
and, in some areas, in a wrinkled or rolled form 
attached to the disks. 
After loading the cells with PnAc, cells were 
subjected to either externally applied oxidative stress 
or ischemia/reperfusion/reoxygenation. Subse- 
quently lipid extracts were made from the dishes and 
PnAc fluorescence and P~ contents of the different 
samples were measured. 
3. Results 
3.1. Insertion of the probe as free acid 
The PnAc insertion assay originally developed by 
Kuypers et al. [13] and Van den Berg et al. [14] for 
use in red blood cells and ghosts, was slightly adapted 
for use in the cardiomyocytes. The optimal concentra- 
tion of PnAc present in the incubation mixture for 30 
min at 37°C (or 40 min at 0°C) appeared to be 4.0 
p~M. Extraction of PnAc from the incubation buffer 
showed that 50-70% of added PnAc was indeed 
inserted in the cells resulting in a final amount of the 
probe of 4 -6  mol% PnAc/phospholipid Pi- 
To assess the stability of the probe, cells were 
labelled with PnAc at 0°C as mentioned above and 
incubated at 37°C in buffer W + for various time 
spans. It can be clearly seen (Fig. 1) that in this case 
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PnAc fluorescence disappears within a few minutes. 
Obviously the probe was degraded rapidly after inser- 
tion and increase of the temperature. Since it is 
known that fatty acid metabolism is a major energy 
source of heart muscle cells we considered the possi- 
bility that [3-oxidation might be the cause of this 
quick degradation. Therefore we pre-incubated the 
cells with DL-aminocarnitine (AC), a competitive in- 
hibitor of carnitine-acyltransferase. By inhibiting the 
acyl-CoA transport into mitochondria, inhibition of 
[3-oxidation is achieved. 
When cells were pre-treated with AC and subse- 
quently incubated at 37°C for extended time periods 
the PnAc fluorescence signal remained constant. Sev- 
eral inhibitor concentrations and incubation periods 
were tested and it appeared that a pre-incubation of 2 
h with 200 p~M DL-aminocarnitine proved to be 
sufficient o obtain a stable fluorescence signal for at 
least 2 additional h of incubation which was suffi- 
cient to carry out the ischemia nd reperfusion exper- 
iments (Fig. 1). Therefore, in all PnAc insertion 
experiments, cells were pre-treated with AC at those 
conditions. 
3.2. Incorporation of the probe in cellular lipids 
To be able to compare peroxidation of free fatty 
acids with peroxidation occurring in the acyl chains 
140 : 
120 T T _ 
i • 
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Fig. 1. Probe stability after PnAc insertion or integration into 
lipids. PnAc was added as mentioned in Section 2. Fluorescence 
was measured after incubations for various time spans in buffer 
W + and plotted as percentage of the fluorescence l vel at t = 0. 
(O :  insertion experiments, - AC; O: insertion experiments, 
+AC;  m: integrated PnAc). Each experiment was repeated at 
least three times, with three samples per time point each. Shown 
are standard eviations of means (SEM). 
of the phospholipids we developed a method to 
metabolically integrate PnAc in the complex lipids of 
cardiomyocytes. It appeared to be sufficient o add 
PnAc to the growth medium for 3 consecutive days. 
To determine the optimal PnAc concentration for 
these integration experiments, a range of concentra- 
tions was tested (10-100 ~M). At a final concentra- 
tion in the growth medium of 30 p~M PnAc the 
integration was optimal. At lower concentrations the 
incorporation was not sufficient o obtain a suitable 
fluorescent signal and at higher concentrations (> 50 
IxM) cell viability was affected. Concentrations above 
70 p~M proved to be lethal. Pre-incubation with AC 
was not necessary in these integration experiments o
obtain a stable fluorescence signal upon labelling 
(Fig. 1). 
To assure that integrated PnAc was indeed cova- 
lently coupled to the lipids, we used a silica column 
to separate in the total lipid extract free fatty acids 
from phosphotipids. Part of the fluorescence signal 
was present in the free fatty acid containing fraction, 
however most of the signal (roughly 50-90%) was 
recovered in the phospholipid fraction. To get a more 
accurate determination of this distribution an extrac- 
tion of free fatty acids alone was performed. A 
comparison between the fluorescence l vels in this 
extract with that of a total lipid extract demonstrated 
that 75% of the total signal resulted from PnAc 
incorporated in complex lipids. The fraction of inte- 
grated PnAc could be further enlarged by adding 
fresh, PnAc free growth medium to the cells a few 
hours before use. This treatment extracted free PnAc 
from the cells and in this way 80 to 90% of PnAc 
present in the cell is integrated in its lipids. Since this 
last approach ensured the highest amount of metabol- 
ically integrated PnAc, we used this method for all 
subsequent integration experiments. 
3.3. Characterization of accumulated PnAc 
To validate both methods of probe insertion in 
cardiomyocytes, the distribution of the PnAc in the 
cell was tested, as well as the sensitivity of the probes 
to oxidative stress. 
To test sensitivity of inserted and integrated PnAc 
to oxidative stress, cells were incubated for various 
time spans with hydrogen peroxide or cumene hydro- 
peroxide. Fig. 2A shows the degradation of inserted, 
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free PnAc and Fig. 2B shows degradation of inte- 
grated PnAc. In both cases PnAc is readily degraded 
in the presence of these peroxides. 
At 5 mM CumOOH the probe is degraded rapidly, 
but this concentration was lethal for the cells after 
about 60 min. At 50 ~M CumOOH a slower perox- 
idative process was observed, and cells survived the 
applied time span of peroxidative stress. In experi- 
ments with cells containing free PnAc, degradation 
with 50 ~zM CumOOH was about as effective as with 
250 txM H20 2. In the case of lipid incorporated 
PnAc 50 lxM CumOOH is less effective than 250 
IxM H202. Inserted, free PnAc seems to be more 
sensitive to peroxidative stress than PnAc integrated 
in lipids. 
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Fig. 2. PnAc degradation due to peroxide induced oxidative 
stress. Cells were incubated with buffer W containing either 250 
IxM H20 2 and 10 IxM ferrous sulphate (11), or 5 mM (0)  or 50 
txM CumOOH (O), as also described in Section 2. (A) insertion 
experiments, (B) results from metabolic integration experiments. 
Fluorescence values are depicted as percentage of the fluores- 
cence value at t = 0. Values are obtained from three separate 
experiments with three samples per time point per experiment. 
Shown is the standard eviation of mean, n = 3. 
Secondly the fraction of PnAc present in the sar- 
colemma of cardiomyocytes was determined. We used 
the gas dissection technique, developed by Langer et 
al. [24] to isolate the plasma membrane of our cells 
and compared the fluorescence in the sarcolemmal 
lipid extract with that in lipid extracts of whole cells. 
The myocardial plasma membranes were shown to be 
devoid of sarcoplasmic reticulum markers and were 
highly enriched in the Na+/K+-ATPase sarcolemmal 
marker. Sarcolemmal recovery was 40-46% [22]. 
Based on the observation that 38% of total lipid- 
phosphorous of the cell is present in the plasma 
membrane [22], the percentage of total PnAc present 
in the plasma membrane was calculated. It was found 
that in aminocarnitine treated cells about 57 +_ 1.3% 
(n = 3) of total PnAc is present in the plasma mem- 
brane. In contrast, labelling without AC pre-treatment 
resulted in a random distribution of the probe, with 
36 + 0.5% (n = 3) of total PnAc present in the sar- 
colemma. Metabolically integrated PnAc appears to 
be enriched in intracellular membrane fractions, be- 
cause only 27 ___ 5.7% (n = 3) of the total PnAc is 
present in the sarcolemma. 
3.4. Lipid peroxidation i  cardiomyocytes 
Applying protocols as described previously 
[19,20,26] myocardial cells were studied under nor- 
moxic conditions; under conditions simulating is- 
chemia and, following this ischemic period, under 
conditions imulating reperfusion with O 2 both in the 
absence (reoxygenation) and presence (repel-fusion) 
of glucose. Three parameters were tested to evaluate 
the conditions of the cells. Loss of cell integrity was 
assessed by measuring the release of lactate dehydro- 
genase and the degree of ischemia was determined by 
measuring intracellular ATP contents. Furthermore, 
cell morphology was checked by means of light 
microscopy. The results shown in Table 1, are com- 
parable to data published before [19,20,26]. Cells 
remain intact during 60 min of ischemia nd the low 
ATP values indicated a severe simulated ischemia. 
Recovery is limited in case reoxygenation is per- 
formed but extensive upon the addition of both oxy- 
gen and glucose for energy production. Under these 
conditions also, the resumption of spontaneous con- 
tractile activity of the cells was observed. 
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Table 1 
LDH release and ATP contents of cardiomyocytes after ischemia 
and reoxygenation/reperfusion 
Incubation time (min) LDH release (%) ATP content (%) 
0I 3.2___1.5 100 ~ 60-  
60 1 4.3 -+ 1.3 28 ± 8 .~ 
120 I 20.6±4.5 18±6 ~ 40 i 
60 I+60 O n.d. 35 ± 12 
60 1 + 60 R n.d. 76 ± 14 
Incubations were performed as mentioned in Section 2, ATP of 
control (no ischemia) was set at 100%. Values are mean_+ SEM, 
n=3.  
I: ischemia, O: reoxygenation, R: reperfusion, n.d.: not deter- 
mined. 
Fig. 3 shows the degradation of PnAc during 
ischemia, both of inserted PnAc and metabolically 
integrated PnAc. For free PnAc, as well as for 
metabolically integrated PnAc, a small decrease in 
fluorescence is visible. In the time span used, about 
15% of the PnAc was lost, a value comparable to 
probe degradation during normoxia. Therefore, we 
conclude that during ischemia no increase in lipid 
peroxidation occurs. 
After 60 rain of simulated ischemia, followed by 
0 -120 min reoxygenation, the PnAc fluorescence 
signal decreased little (Fig. 4). As the observed de- 
cline is comparable to the decline occurring during 
ischemia nd the control normoxic situation, it can be 
concluded that also during reoxygenation lipid per- 
oxidation is at a low level and not increased in 
comparison with normoxic and ischemic conditions. 
120 
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~ 80 
g 6o 
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Fig. 3. PnAc degradation during ischemia. Cells were subjected 
to various time spans of ischemia as described in Section 2. 
Lipids were extracted and fluorescence was measured. All values 
are depicted as percentage of fluorescence at t = 0. O: insertion 
experiments; ©: integration experiments, n = 3, shown are SEM. 
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Fig. 4. Degradation of PnAc during reoxygenation a d reperfu- 
sion. Depicted are relative fluorescence values (F~_ 0 = 100%). 
Cells were first subjected to ischemia for 60 min as described 
before and subsequently placed in fresh buffer W for reoxy- 
genation (O) or buffer W + for reperfusion (0). (A) Insertion 
experiments, (B) integration experiments, n = 3, shown are SEM. 
This was the case for both inserted (Fig. 4A) and 
integrated PnAc (Fig. 4B). 
When on the other hand recovery from ischemia 
was obtained by the addition of both oxygen and 
glucose, i.e., reperfusion, increased degradation of 
PnAc was obvious. Again the results for inserted 
PnAc (Fig. 4A) and integrated PnAc (Fig. 4B) were 
comparable. Apparently reflow of oxygen alone is 
not sufficient o induce large scale peroxidative dam- 
age; availability and probably the consumption of 
substrates i necessary. 
4. Discuss ion 
Damage to cellular structure and impairment of 
biological functions during several degenerative pro- 
cesses, and in a steadily increasing number of dis- 
eased states, has been ascribed to the production of 
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free radicals and subsequent peroxidation of mem- 
brane lipids. Methods to investigate this lipid per- 
oxidation are available, be it that most are time 
consuming and/or indirect, e.g., measuring break- 
down products of lipid peroxides, but not the damage 
to lipids itself (for review see [27]) 
A more direct way to detect lipid peroxidation was 
offered by the use of parinaric acid as a peroxidation 
sensitive membrane probe [13]. cis-Parinaric acid is a 
highly fluorescent, polyunsaturated fatty acid and 
destruction of any part of its conjugated ouble bond 
system, for example due to an attack by reactive 
oxygen species, causes the loss of its fluorescence. In
this way, its fluorescent properties and peroxidation 
susceptibility are united and the disappearance of
PnAc fluorescence is direct evidence for lipid per- 
oxidation. The method has been successfully applied 
to investigate lipid peroxidation in erythrocytes and 
ghosts [14], sarcoplasmic reticulum [28], low density 
lipoprotein particles [29], and submitochondrial parti- 
cles [30]. Hedley and Chow [31] used PnAc in flow 
cytometric measurements of lipid peroxidation. 
In this study, we applied the methodology to inves- 
tigate the initial stages of lipid peroxidation in cul- 
tured neonatal cardiomyocytes during ischemia, re- 
oxygenation and reperfusion, i.e., reoxygenation i
the presence of glucose necessary to resume energy 
production. Two probe conditions were applied: The 
insertion as free acid and the incorporation of PnAc 
in membrane lipids. 
The original method for PnAc insertion, as devel- 
oped by Kuypers et al. [13], had to be adapted for use 
in cardiomyocytes with respect o the optimal con- 
centration and optimal incubation time. During these 
experiments it appeared that PnAc was quickly de- 
graded, which is understandable b cause fatty acids 
are a major energy source of heart cells. This 
metabolic degradation could be eliminated and a 
stable fluorescence l vel was reached by pre-incuba- 
tion of the cells with an inhibitor of [3-oxidation, 
DL-aminocarnitine (AC). At the chosen conditions up 
to 60% of the PnAc present in the growth medium or 
the incubation buffer was inserted. Additional experi- 
mentation showed that under these conditions the 
probe is not equally distributed over the plasma and 
intracellular membranes. Whereas 38% of total phos- 
pholipid is present in the plasma membrane up to 
57% of the total inserted PnAc can be found here, an 
effect which has to be ascribed to the fact that fatty 
acid transport to the mitochondrial inner membrane is 
blocked by the aminocarnitine, resulting in a cytoso- 
lic accumulation of free fatty acids (FFA) [32]. This 
might subsequently lead to a reduced FFA flux across 
the sarcolemma into the cytoplasm and accumulation 
of PnAc in the sarcolemma. 
PnAc could also be integrated in the phospholipids 
of the cell. Experiments with other fatty acids, for 
example arachidonic acid, showed that addition of 
this fatty acid to the growth medium resulted in 
metabolic integration in the lipids [33]. Recently Ri- 
toy et al. [34] reported that they were also able to 
integrate PnAc metabolically in phospholipids of eu- 
karyotic cells. They used four different rapidly divid- 
ing secondary cell lines and showed that PnAc bound 
to human serum albumin (1.8 mM PnAc) was inte- 
grated in the phospholipids of these cells within 2 h. 
Because of the occurrence of cell divisions, lipid 
turnover in these cells is much higher than in primary 
cell lines, like the terminally differentiated, non-di- 
viding cardiomyocytes, and shorter incubation times 
will therefore be sufficient in those cells. Not only 
incubation times but also the concentration of added 
PnAc may be of importance as cytotoxicity of PnAc 
in undifferentiated, malignant cells, was reported by 
[35], even at low concentrations (5 IxM) and after 
24-48 h incubation time. Comparable differentiated 
cells were resistant o concentrations of PnAc up to 
30 poM. The difference in sensitivity was thought o 
be due to differences in uptake rates, which were 3-4 
times higher in malignant, undifferentiated cells. It 
turned out that incorporation of PnAc in the car- 
diomyocytes could be obtained by the presence of 
PnAc in the growth medium for 3 consecutive days at 
an initial concentration f 30 p~M. Under these condi- 
tions, a substantial part of the PnAc is taken up by 
the cell. Analysis of the fate of this PnAc showed that 
not all of the fatty acid is incorporated in complex 
lipids: a substantial part remains present as free acid. 
Incubating the cells however with PnAc-free growth 
medium, removed most of this free acid. From the 
incorporated PnAc 27% appeared to be present in the 
plasma membrane lipids. 
When cardiomyocytes, loaded with the fluorescent 
probe, were incubated with the peroxidation i ducing 
molecules cumene hydroperoxide (CumOOH) or hy- 
drogen peroxide (H20 2) a rapid loss of fluorescence 
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was observed. CumOOH appeared to be more effec- 
tive than H202, which is probably caused by the fact 
that CumOOH is a more hydrophobic peroxide than 
H20 2. It is inserted in the plasma and intracellular 
membranes immediately and forms radicals in the 
direct vicinity of the fatty acids. 
Free parinaric acid has a higher sensitivity for 
peroxidative stress than parinaric acid integrated in 
complex lipids. Comparable results were obtained 
before in model systems in which the susceptibility 
of free PnAc and PnPC (1-palmitoyl-2-parinaroyl- 
phosphatidylcholine) to applied oxidative stress were 
compared [13]. The explanation of this phenomenon 
could be that the free fatty acid may be more mobile 
than the parinaroyl-containing lipids, covering a big- 
ger membrane surface in a given time span, thereby 
increasing its changes to encounter a free radical 
species. 
Taken together we conclude that parinaric acid 
(free or lipid incorporated) can be used to provide the 
membranes of cardiomyocytes with a convenient 
probe to investigate early events in lipid peroxidation 
during ischemia and reperfusion. PnAc fluorescence 
is stable for at least 2 h under normoxic conditions, 
the probe is sensitive to peroxidative stress and the 
distribution of the probe in the cell is known. 
During ischemia itself we observed no increased 
lipid peroxidation. After 2 h of simulated ischemia 
about 15% of initial fluorescence l vel was lost (Fig. 
3) but this decrease was comparable to the decrease 
under normoxic conditions (Fig. 1). The observed 
absence of lipid peroxidation might indicate that also 
radical generation is diminished during simulated 
ischemia in our system. Data presented by others are 
contradictory and seem to depend on the sensitivity 
and suitability of the applied method or on the type 
of material used for these studies (cultured cells vs. 
perfused hearts). Zweier et al. [5] used electron para- 
magnetic resonance spectroscopy (EPR) to show that 
reactive oxygen centred free radicals are generated in
hearts during the ischemic period itself and that a 
burst of oxygen radical generation occurred within 
moments of reperfusion. On the other hand, Lesnef- 
sky et al. [36], using electron spin resonance spec- 
troscopy (ESR) did not detect radical formation dur- 
ing the ischemic insult itself, but detected a sudden 
increase in free radicals during reperfusion. Also 
enhanced chemiluminescence was used to measure 
radical formation directly [7] and it was shown that 
radical formation decreased during ischemia but 
markedly increased uring the first 3-5 min of reper- 
fusion. Furthermore, the level of radical production 
during reperfusion varied with the duration of the 
preceding ischemic period [37,38]. In agreement with 
these data is our observation that during reperfusion a 
significant increase in lipid peroxidation occurred, 
and not during the ischemic period. 
To exclude the possibility that the decrease in 
PnAc signal intensity during reperfusion is due to 
[3-oxidation instead of lipid peroxidation, we inhib- 
ited [3-oxidation using DL-aminocarnitine (AC) in the 
insertion experiments. Pre-incubation with AC and its 
presence during PnAc insertion is sufficient o inhibit 
[3-oxidation for the whole time course of the ischemic 
and reperfusion episodes (Fig. 1). Prolonged incuba- 
tion with AC did not result in a further stabilization 
of the PnA fluorescence signal. During experiments 
in which the PnAc had been metabolically integrated 
into phospholipid molecules, the fatty acid is not 
available for [3-oxidation. Furthermore, the same de- 
crease of PnA intensity was observed uring reperfu- 
sion in integration experiments compared to the inser- 
tion experiments (Fig. 4). These observations strongly 
indicate that the loss of PnAc fluorescence during 
reperfusion indeed should be ascribed to lipid per- 
oxidation, rather than to its degradation in the [3- 
oxidation pathway. 
Increased lipid peroxidation during reperfusion fol- 
lowing simulated ischemia was reported by several 
groups. Blasig et al. [39] showed that during reperfu- 
sion 4-hydroxynonenal (HNE) levels increased. HNE 
is a specific product of lipid peroxidation and it is 
formed after interactions with free radicals only. Dur- 
ing reperfusion also an increase of conjugated ienes 
and the liberation of thiobarbituretic acid reactive 
substances (TBARS) such as malondialdehyde 
(MDA) have been observed [36-38]. Our data fur- 
thermore show that during reoxygenation, i.e., the 
reintroduction of oxygen alone, lipid peroxidation 
does not occur. The combined supplementation f 
both oxygen and glucose, which can be used to 
supply energy to the system, are required to lead to 
an increase in the lipid peroxidation. The latter obser- 
vation suggests that mitochondrial activity is in- 
volved in the generation of radicals and the induction 
of peroxidative damage. Such an involvement of 
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mitochondrial activity has been put forward indeed 
recently, when Piantadosi and Zhang showed that 
formation of radicals in rat brain after ischemia takes 
place in the mitochondria [40]. 
Several mitochondrial enzymes are affected uring 
ischemia. Borutaite et al. [41] showed that the main 
effects of ischemia on mitochondrial respiration are 
an inhibition of the respiratory chain, some inhibition 
of the phosphorylation system and an increase of the 
proton leak. Under normal conditions 1% or 2% of 
the oxygen reduced in the respiratory chain is con- 
verted into reactive oxygen species via, i.e., the 
reduction of 02 by a single electron to form Oy. 
Superoxide anion rapidly dismutates to H202 in the 
mitochondria either spontaneously or enzymatically 
via manganese superoxide dismutase. The rate of 02 
production by mitochondria increases as the mito- 
chondrial [Ca 2+] increases and/or the pH decreases. 
Furthermore, the rate of H20 2 production is a func- 
tion of the oxidation-reduction state of the electron 
carriers; as the carriers become reduced, the rate of 
H20 2 production increases [8]. Since during is- 
chemia a lowering of the pH, a mitochondrial Ca 2+ 
overload, as well as a full reduction of the electron 
transport system occurs, this might set the stage for 
the production of ROS upon restoration of 02 and 
substrate supply. This then subsequently might lead 
to the observed lipid peroxidation as determined in 
the present study. 
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